NPI registry status
Active
2026 NPPES data Rheumatology Physician NPI 1780812461 D.O.
Verify on CMS → Mark Tratenberg, D.O.
Rheumatology Physician in Morristown, New Jersey.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 6,377 in Rheumatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 277 beneficiaries · Rheumatology Physician avg: 2K
Generic prescribing
89%
generic claims · 11% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
64.5/100
▼ 19 pts below national avg 83.5 · Mid-tier
Industry payments
$4.4K
220 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Mark Tratenberg, D.O. reported a CMS MIPS final score of 64.5/100 - below the 83.5 national average - and filed 1,204 Medicare Part D claims in 2024.
- 64.5/100
- MIPS score · -19 vs avg
- 1K
- Part D claims, 2024
- 89%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Mark Tratenberg, D.O.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1780812461), first enumerated 07/01/2009.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,204 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 64.5/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
2 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$4.4K in reported industry payments (220 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1780812461 · Rheumatology Physician
NPI-10 · ENUM-MID · TAX-MID · MIPS-LOW · RX-MID · BOOK-THIN · PHOTO-FINISH
- NPI-10 1780812461
- ENUM-MID 2009
- TAX-MID 6K Rheumatology Physician
- MIPS-LOW 64.5/100
- RX-MID 1,204
- BOOK-THIN 228 in New Jersey
- PHOTO-FINISH Gurjot Basra, M.D. · ±0.2
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Michael Thakor, …
Michael Thakor, MD
64.2 MIPS pts
- Gurjot Basra, M.…
Gurjot Basra, M.D.
64.3 MIPS pts
- Tratenberg · thi…
Tratenberg · this provider
64.5 MIPS pts
- Justin Reed, D.O…
Justin Reed, D.O.
64.7 MIPS pts
- Mahmood Pazirand…
Mahmood Pazirandeh, MD, FACP, FACR
64.7 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Mark Tratenberg, D.O.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
65 ≥ 7th percentile 7% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Mark Tratenberg, D.O. sits
This provider among rheumatology physician peers
Across the 1,970 rheumatology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Mark Tratenberg, D.O. writes more Part D claims than 33% of them and scores higher on MIPS quality than 7% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one rheumatology physician peer from a representative sample of 60; the gold marker is Mark Tratenberg, D.O.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Mark Tratenberg, D.O. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mark Tratenberg, D.O.?
Below national averagePrimary specialty
Rheumatology Physician
Medicare Part D claims
1,204 41% vs specialty avg
MIPS final score
64.5/100 19 pts vs avg
Specialty distribution in New Jersey
How Rheumatology Physician compares to other specialties among New Jersey providers
Medicare quality performance, MIPS
Mark Tratenberg, D.O.'s 2023 MIPS final score plotted against the Rheumatology Physician national average
- MIPS Final Score
- 64.5/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1780812461 |
|---|---|
| Specialty | Rheumatology Physician |
| Credentials | D.O. |
| Gender | Male |
| NPI Issued | 07/01/2009 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
64.4772
Final Score
Measured-score avg: 83.5
84.3814
Quality
47.2093
Cost
70
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Mark Tratenberg, D.O. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Allergy And Arthritis Associates
Dover, NJ
Arthritis And Allergy Associates LLC
Dover, NJ
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mark Tratenberg, D.O.. Source: openpaymentsdata.cms.gov.
Total received
$4.4K
Largest payer
ABBVIE INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
Mark Tratenberg, D.O. - brand share 11.0%
Rheumatology Physician average
11% brand-name claims vs 89% generic, on 1,204 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
1,204
Total Claims
$908K
Total Drug Cost
277
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 2,207.867
- Total Day Supply
- 62,985
- Brand vs Generic
- 11% brand / 89% generic
- Brand Drug Cost
- $881K
- Generic Drug Cost
- $27K
Patient Demographics
- Average Patient Age
- 73.8 years
- Avg HCC Risk Score
- 1.46
- Gender Split
- 64% female / 36% male
- Age Distribution
- <65: 19, 65-74: 135, 75-84: 96, 85+: 27
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Mark Tratenberg, D.O. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Hydroxychloroquine…
Hydroxychloroquine Sulfate
133 claims
- Prednisone
Prednisone
129 claims
- Methotrexate
Methotrexate
123 claims
- Methylprednisolone
Methylprednisolone
111 claims
- Colchicine
Colchicine
92 claims
- Allopurinol
Allopurinol
87 claims
- Alendronate Sodium
Alendronate Sodium
78 claims
- Celecoxib 53
Celecoxib
53 claims
| Drug | Claims |
|---|---|
| Hydroxychloroquine Sulfate | 133 |
| Prednisone | 129 |
| Methotrexate Methotrexate Sodium | 123 |
| Methylprednisolone | 111 |
| Colchicine | 92 |
| Allopurinol | 87 |
| Alendronate Sodium | 78 |
| Celecoxib | 53 |
| Meloxicam | 48 |
| Duloxetine Hcl | 27 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Rheumatology Physician Overview
How Mark Tratenberg, D.O. fits within the Rheumatology Physician landscape nationally.
6,377
Rheumatology Physician Providers in US
52
States with Rheumatology Physician
2,058
Avg Claims per Provider
Mark Tratenberg, D.O.'s 1,204 claims are below the specialty average of 2,058.
Nationwide Rheumatology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Tratenberg, both outside New Jersey so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (64.5 here).
Same NPPES enumeration year (2009)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Rheumatology Physician Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as Tratenberg.
One of 228 Rheumatology Physician providers enrolled in New Jersey, 5 are shown here.
Dr. Mutahir Abidi
M.D.
Brick, NJ
Dr. Shawn Abraham
M.D.
Voorhees, NJ
Dr. Raymond Adelizzi
DO
Stratford, NJ
Dr. Humaira Adenwalla
M.D.
Lawrenceville, NJ
Dr. Iqra Aftab
MD
Egg Harbor Township, NJ
Compare Rheumatology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Mark Tratenberg, D.O.'s specialty? ▼
Mark Tratenberg, D.O. specializes in Rheumatology Physician and practices in Morristown, New Jersey. Credentials: D.O..
How much does Mark Tratenberg, D.O. prescribe under Medicare Part D? ▼
In 2024, Mark Tratenberg, D.O. wrote 1,204 Medicare Part D claims totaling $908K in drug costs for 277 beneficiaries.
What is Mark Tratenberg, D.O.'s Medicare quality score? ▼
Mark Tratenberg, D.O. has a CMS MIPS Final Score of 64.5/100 (Quality: 84.4, Cost: 47.2). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Mark Tratenberg, D.O. located? ▼
Mark Tratenberg, D.O. is located at 435 SOUTH ST, Morristown, NJ, 07960. Phone: (973) 540-9198.
What is Mark Tratenberg, D.O.'s NPI number? ▼
Mark Tratenberg, D.O.'s National Provider Identifier (NPI) is 1780812461, issued on 07/01/2009.
Does Mark Tratenberg, D.O. prescribe more brand-name or generic drugs? ▼
Mark Tratenberg, D.O.'s prescribing is 11% brand-name and 89% generic drugs by claim count, with $881K in brand drug costs.
How many Rheumatology Physician providers are there in the US? ▼
There are 6,377 Rheumatology Physician providers across 52 states in the US. The average Rheumatology Physician provider writes 2,058 Medicare Part D claims per year.
What drugs does Mark Tratenberg, D.O. prescribe most often? ▼
Based on 2024 Medicare Part D data, Mark Tratenberg, D.O.'s most frequently prescribed drugs include Hydroxychloroquine Sulfate, Prednisone, Methotrexate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mark Tratenberg, D.O. accept Medicare? ▼
Mark Tratenberg, D.O. appears in CMS Medicare data with 1,204 Part D claims and 277 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mark Tratenberg, D.O.'s credentials? ▼
Mark Tratenberg, D.O.'s NPI is 1780812461 with credentials D.O.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.